Tg Therapeutics Inc Revenue per Employee (TGTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Tg Therapeutics Inc   (NASDAQ: TGTX)
 

Tg Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 70.27% in the second quarter 2026, year on year to cumulative value of $800 million, Tg Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,003,850, this marks a new company high.
Within the Healthcare sector Employees of 39 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 497, from total ranking in previous quarter at 702. Tg Therapeutics Inc has 399 employees.


What is Sales per Employee Ratio?







TGTX Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 70.27 % 69.56 % 78 % 92.79 % 92.13 %
Sales per Employee (TTM) $ 2,003,850 1,755,261 1,544,579 1,333,078 1,138,015
TGTX's Total Ranking # 497 # 702 # 670 # 781 # 897
Seq. Revenue Change 17.28 % 6.41 % 19.09 % 14.57 % 16.79 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 40
Overall Market # 497

Revenue per Employee Statistics
High Average Low
$ 2,003,850 $ 256,331 $ 381
(Jun 30 2026)   (Dec 31 2020)



Financial Statements
Tg Therapeutics Inc 's Revenue MRQ $ 240 Millions Visit TGTX's Income Statement
Tg Therapeutics Inc 's Revenues TTM $ 800 Millions Visit TGTX's aggregate revenue growth
What are TGTX's Sales? Visit TGTX's Sales by Segment




Other Ratios
Tg Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TGTX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TGTX's Competitors
Revenue per Employee for TGTX's Suppliers
Revenue per Employee for TGTX's Customers

You may also want to know
TGTX's Sales Growth Rates TGTX's Pe Price to earnings ratio TGTX's Receivables Turnover Ratio TGTX's Stock Quote
TGTX's Net Income Growth Rates TGTX's Ps Price to Sales ratio TGTX's Sales per Employee TGTX's Asset Turnover Ratio
TGTX's Net Margin TGTX's Pb Price to Book ratio TGTX's Financial Strength Ratios TGTX's Dividend Payout Ratio
Date modified: 2026-09-09T22:26:19+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million
Amgen Inc   2,930,384.62 $ 38,095.000  Million 13,000 
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.